Virus–host interplay in hepatitis B virus infection and epigenetic treatment strategies
- 19 May 2017
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 284 (21) , 3550-3572
Abstract
Worldwide, chronic hepatitis B virus (HBV) infection is a major health problem and no cure exists. Importantly, hepatocyte intrusion by HBV particles results in a complex deregulation of both viral and host cellular genetic and epigenetic processes. Among the attempts to develop novel therapeutic approaches against HBV infection, several options targeting the epigenomic regulation of HBV replication are gaining attention. These include the experimental treatment with ‘epidrugs’. Moreover, as a targeted approach, the principle of ‘epigenetic editing’ recently is being exploited to control viral replication. Silencing of HBV by specific rewriting of epigenetic marks might diminish viral replication, viremia, and infectivity, eventually controlling the disease and its complications. Additionally, epigenetic editing can be used as an experimental tool to increase our limited understanding regarding the role of epigenetic modifications in viral infections. Aiming for permanent epigenetic reprogramming of the viral genome without unspecific side effects, this breakthrough may pave the roads for an ambitious technological pursuit: to start designing a curative approach utilizing manipulative molecular therapies for viral infections in vivo.Keywords
Funding Information
- Universitair Medisch Centrum Groningen
This publication has 181 references indexed in Scilit:
- Inactivation of Hepatitis B Virus Replication in Cultured Cells and In Vivo with Engineered Transcription Activator-Like Effector NucleasesMolecular Therapy, 2013
- Targeted gene knockout by direct delivery of zinc-finger nuclease proteinsNature Methods, 2012
- Hepatitis B virus regulatory HBx protein binding to DDB1 is required but is not sufficient for maximal HBV replicationVirology, 2012
- Regulation of chromatin by histone modificationsCell Research, 2011
- Replication of the hepatitis B virus requires a calcium-dependent HBx-induced G1 phase arrest of hepatocytesVirology, 2010
- Zinc-finger Nucleases as a Novel Therapeutic Strategy for Targeting Hepatitis B Virus DNAsMolecular Therapy, 2010
- Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA functionProceedings of the National Academy of Sciences, 2009
- Methylation Regulates Hepatitis B Viral Protein ExpressionThe Journal of Infectious Diseases, 2009
- Comprehensive Genetic and Epigenetic Analysis of Occult Hepatitis B from Liver Tissue SamplesClinical Infectious Diseases, 2008
- An improved zinc-finger nuclease architecture for highly specific genome editingNature Biotechnology, 2007